Artificial intelligent assistant

mesoblast

answer Answers

ProphetesAI is thinking...

MindMap

Sources

1
Home - Mesoblast Ltd
Mesoblast is using its proprietary mesenchymal lineage cell technology platform to develop and commercialize innovative allogeneic cellular medicines to treat ... www.mesoblast.com
www.mesoblast.com 0.0 10.0 0.0
2
Mesoblast - Wikipedia
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back ... en.wikipedia.org
en.wikipedia.org 0.0 5.0 0.0
3
Mesoblast Limited (MESO) Stock Price, News, Quote & History
Mesoblast Limited, together with its subsidiaries, engages in the development of regenerative medicine products in Australia, the United States, Singapore, ... finance.yahoo.com
finance.yahoo.com 0.0 3.0 0.0
4
mesoblast
mesoblast Biol. (ˈmɛsəʊblæst) [f. meso- + -blast.] The middle layer of the blastoderm, between the epiblast and the hypoblast. Also attrib. Hence ˈmesoblasted a., having a mesoblast.1857 Agassiz Contrib. Nat. Hist. U.S.A. II. 467 The mesoblast of the yolk cell. Ibid. II. 617 Some of the mesoblasted ... Oxford English Dictionary
prophetes.ai 0.0 3.0 0.0
5
Mesoblast News - X
Mesoblast Limited (ASX:MSB; Nasdaq:MESO) is a global leader in developing allogeneic cellular medicines for inflammatory diseases. x.com
x.com 0.0 2.0 0.0
6
MSB.AX - | Stock Price & Latest News - Reuters
Mesoblast Limited is an Australia-based company, which is engaged in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and ... www.reuters.com
www.reuters.com 0.0 2.0 0.0
7
Mesoblast Shareholder Class Action - Omni Bridgeway
The Consolidated Class Action alleges that Mesoblast contravened its continuous disclosure obligations and engaged in misleading or deceptive conduct. portal.omnibridgeway.com
portal.omnibridgeway.com 0.0 1.0 0.0
8
Mesoblast Ltd (MSB) - Morningstar
Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment ... www.morningstar.com
www.morningstar.com 0.0 1.0 0.0
9
Mesoblast Ltd. Stock Quote (Australia: Sydney) - MSB - MarketWatch
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology ... www.marketwatch.com
www.marketwatch.com 0.0 1.0 0.0
10
Mesoblast Ltd. - AnnualReports.com
Mesoblast Limited engages in the development, manufacture, and commercialization of biologic products for the field of regenerative medicine. www.annualreports.com
www.annualreports.com 0.0 1.0 0.0
11
mesoblastic
mesoblastic, a. (mɛsəʊˈblæstɪk) [f. mesoblast + -ic.] Of or pertaining to the mesoblast.1874 F. M. Balfour in Q. Jrnl. Microsc. Sci. XIV. 342 Primitively a true hypoblastic structure which has only by adaptation become an apparently mesoblastic one. 1896 Allbutt's Syst. Med. I. 201 Histologically al... Oxford English Dictionary
prophetes.ai 0.0 0.90000004 0.0
12
Prochymal
Also known as remestemcel-L, Prochymal was sold to Australia-based Mesoblast in 2013 at which time its brand name was changed to Ryoncil. wikipedia.org
en.wikipedia.org 0.0 0.6 0.0
13
mesoderm
mesoderm (ˈmɛsəʊdɜːm) [f. Gr. µέσο-ς middle + δέρµα skin.] 1. Bot. a. ‘The middle layer of tissue in the shell of the spore-case of an urn-moss’ (Treas. Bot. 1866). b. ‘The middle layer of the bark’ (Syd. Soc. Lex. 1890).1874 Q. Jrnl. Microsc. Sci. XIV. 159 As soon as the two primary germ-lamellæ be... Oxford English Dictionary
prophetes.ai 0.0 0.6 0.0
14
mesenchyma
‖ mesenchyma Biol. (mɛˈsɛŋkɪmə) Also anglicized mesenchyme (ˈmɛsɛŋkaɪm). [mod.L. mesenchyma, f. Gr. µέσ-ος middle + ἔγχυµα infusion.] The cellular tissue which, arising from the hypoblast or the epiblast, constitutes, in some of the lower forms of animal life, the mesoblast. Also attrib. in mesenchy... Oxford English Dictionary
prophetes.ai 0.0 0.3 0.0
15
Osiris Therapeutics
In 2013, Osiris sold its MSC drug and associated patents to Mesoblast of Australia and the drug was renamed Ryoncil. The Cardiothoracic Surgical Trials Network, funded by the National Institutes of Health, and Mesoblast (the owner of the product) commenced that trial wikipedia.org
en.wikipedia.org 0.0 0.3 0.0